Pathway analysis of cervical cancer genome-wide association study highlights the MHC region and pathways involved in response to infection

Human Molecular Genetics

Volumn 23, Issue 22, 2014, Pages 6047-6060

  Chen, Dan ^a,b   Enroth, Stefan ^a   Ivansson, Emma ^a   Gyllensten, Ulf ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HERPES SIMPLEX; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STAPHYLOCOCCUS INFECTION; UTERINE CERVIX CANCER; ADULT; CASE CONTROL STUDY; CAUCASIAN; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MIDDLE AGED; SWEDEN; UTERINE CERVIX TUMOR;

ADULT; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFECTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SWEDEN; UTERINE CERVICAL NEOPLASMS;

EID: 84911382314     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu304     Document Type: Article

References (55)

1. Arbyn, M., Castellsagué, X., de Sanjosé, S., Bruni, L., Saraiya, M., Bray, F. and Ferlay, J. (2011) Worldwide burden of cervical cancer in 2008. Ann. Oncol., 22, 2675-2686.
2. Bosch, F.X., Lorincz, A.,Muñoz, N., Meijer, C.J. and Shah, K.V. (2002) The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol., 55, 244-265.
3. Magnusson, P.K., Sparén, P. and Gyllensten, U.B. (1999) Genetic link to cervical tumours. Nature, 400, 29-30.
4. Chen, D., Juko-Pecirep, I., Hammer, J., Ivansson, E., Enroth, S., Gustavsson, I., Feuk, L., Magnusson, P.K., McKay, J.D., Wilander, E. et al. (2013) Genome-wide association study of susceptibility loci for cervical cancer. J. Natl.Cancer Inst., 105, 624-633.
5. Wang, K., Li, M. and Hakonarson,H. (2010) Analysing biological pathways in genome-wide association studies. Nat. Rev. Genet., 11, 843-854.
6. Barabasi, A.L. (2007) Network medicine-from obesity to the "diseasome". N. Engl. J. Med., 357, 404-407.
7. Askland, K., Read, C. and Moore, J. (2009) Pathways-based analyses of whole-genome association study data in bipolar disorder reveal genes mediating ion channel activity and synaptic neurotransmission. Hum. Genet., 125, 63-79.
8. Lesnick, T.G., Papapetropoulos, S., Mash, D.C., Ffrench-Mullen, J., Shehadeh, L., de Andrade, M., Henley, J.R., Rocca, W.A., Ahlskog, J.E. and Maraganore, D.M. (2007) A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet., 3, e98.
9. Wang, K., Li, M. and Bucan, M. (2007) Pathway-based approaches for analysis of genomewide association studies. Am. J. Hum. Genet., 81, 1278-1283.
10. Menashe, I., Maeder, D., Garcia-Closas, M., Figueroa, J.D., Bhattacharjee, S., Rotunno, M., Kraft, P., Hunter, D.J., Chanock, S.J., Rosenberg, P.S. et al. (2010) Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade. Cancer Res., 70, 4453-4459.
11. O'Dushlaine, C., Kenny, E., Heron, E., Donohoe, G., Gill,M.and Morris, D., International Schizophrenia Consortium and Corvin, A. (2011) Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol. Psychiatry, 16, 286-292.
12. Deelen, J., Uh, H.W., Monajemi, R., van Heemst, D., Thijssen, P.E., Böhringer, S., van den Akker, E.B., de Craen, A.J., Rivadeneira, F., Uitterlinden, A.G. et al. (2013) Gene set analysis of GWAS data for human longevity highlights the relevance of the insulin/IGF-1 signaling and telomere maintenance pathways. Age (Dordr), 35, 235-249.
13. Ivansson, E.L., Juko-Pecirep, I., Erlich, H.A. and Gyllensten, U.B. (2011) Pathway-based analysis of genetic susceptibility to cervical cancer in situ: HLA-DPB1 affects risk in Swedish women. Genes Immunol., 12, 605-614.
14. O'Dushlaine, C., Kenny, E., Heron, E.A., Segurado, R., Gill, M., Morris, D.W. and Corvin, A. (2009) The SNP ratio test: pathway analysis of genome-wide association datasets. Bioinformatics, 25, 2762-2763.
15. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., Maller, J., Sklar, P., de Bakker, P.I., Daly, M.J. et al. (2007)PLINK:a tool set for whole-genome association and population based linkage analyses. Am. J. Hum. Genet., 81, 559-575.
16. Ramanan, V.K., Shen, L., Moore, J.H. and Saykin, A.J. (2012) Pathway analysis of genomic data: concepts, methods, and prospects for future development. Trends Genet., 28, 323-332.
17. Shi, Y., Li, L., Hu, Z., Li, S., Wang, S., Liu, J., Wu, C., He, L., Zhou, J., Li, Z. et al. (2013) A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12. Nat. Genet., 45, 918-922.
18. Daniel, D., Meyer-Morse, N., Bergsland, E.K., Dehne, K., Coussens, L.M. and Hanahan, D. (2003) Immune enhancement of skin carcinogenesis by CD4+ T cells. J. Exp. Med., 197, 1017-1028.
19. Botto, M., Kirschfink, M., Macor, P., Pickering, M.C., Würzner, R. and Tedesco, F. (2009) Complement in human diseases: lessons from complement deficiencies. Mol. Immunol., 46, 2774-2783.
20. Nilsson, S.C., Sim, R.B., Lea, S.M., Fremeaux-Bacchi, V. and Blom, A.M. (2011) Complement factor I in health and disease. Mol. Immunol., 48, 1611-1120.
21. Schumaker, V.N., Zavodszky, P. and Poon, P.H. (1987) Activation of the first component of complement. Annu. Rev. Immunol., 5, 21-42.
22. Megyeri, M., Harmat, V., Major, B.,Végh,Á., Balczer, J.,Héja, D., Szilágyi, K., Datz, D., Pál, G., Závodszky, P. et al. (2013) Quantitative characterization of the activation steps of mannan-binding lectin (MBL)-associated serine proteases (MASPs) points to the central role of MASP-1 in the initiation of the complement lectin pathway. J. Biol. Chem., 288, 8922-8934.
23. Takahashi, M., Mori, S., Shigeta, S. and Fujita, T. (2007) Role of MBL-associated serine protease (MASP) on activation of the lectin complement pathway. Adv. Exp. Med. Biol., 598, 93-104.
24. Skjoedt, M.O., Hummelshoj, T., Palarasah, Y., Honore, C., Honore, C., Koch, C., Skjodt, K. and Garred, P. (2010) A novel mannose-binding lectin/ ficolin-associated protein is highly expressed in heart and skeletal muscle tissues and inhibits complement activation. J. Biol. Chem., 285, 8234-8243.
25. Yang, D., Chen, Q., Gertz, B., He, R., Phulsuksombati, M., Ye, R.D. and Oppenheim, J.J. (2002) Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation. J. Leukoc. Biol., 72, 598-607.
26. Hynes, R.O. (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell, 69, 11-25.
27. Hogg, N., Stewart, M.P., Scarth, S.L., Newton, R., Shaw, J.M., Law,S.K. and Klein, N. (1999)Anovel leukocyte adhesion deficiency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-1. J. Clin. Invest., 103, 97-106.
28. Eun, Y.G., Kim, S.K., Chung, J.H. and Kwon, K.H. (2013) Association study of integrins beta 1 and beta 2 gene polymorphism and papillary thyroid cancer. Am. J. Surg., 205, 631-635.
29. Carlow, D.A., Gossens, K., Naus, S., Veerman, K.M., Seo, W. and Ziltener, H.J. (2009) PSGL-1 function in immunity and steady state homeostasis. Immunol. Rev., 230, 75-96.
30. Bahbouhi, B., Berthelot, L., Pettré, S., Michel, L., Wiertlewski, S., Weksler, B., Romero, I.A., Miller, F., Couraud, P.O., Brouard, S. et al. (2009) Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line. J. Leukoc. Biol., 86, 1049-1063.
31. Scalabrini, D., Galimberti, D., Fenoglio, C., Comi, C., De Riz, M., Venturelli, E., Castelli, L., Piccio, L., Ronzoni, M., Lovati, C. et al. (2005) P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis. Neurosci. Lett., 388, 149-152.
32. Gupta, R., Warren, T. and Wald, A. (2007) Genital herpes. Lancet, 370, 2127-2137.
33. Lulitanond, V., Chantratita, W., Thammaprasert, K., Nimmanahaeminda, K., Matangkasombut, P. and Yoosook, C. (1994) Detection of herpes simplex virus type 2 Bgl II N fragment in paraffin-embedded cervical tissue sections using nested polymerase chain reaction. Mol. Cell Probes, 8, 441-447.
34. Yamakawa, Y., Forslund, O., Chua, K.L., Dillner, L., Boon, M.E. and Hansson, B.G. (1994) Detection of the BC 24 transforming fragment of the herpes simplex virus type 2 (HSV-2) DNA in cervical carcinoma tissue by polymerase chain reaction (PCR). APMIS, 102, 401-406.
35. Smith, J.S., Herrero, R., Bosetti, C., Muñoz, N., Bosch, F.X., Eluf-Neto, J., Castellsagué, X., Meijer, C.J., Van den Brule, A.J., Franceschi, S. et al. (2002) Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J. Natl. Cancer Inst., 94, 1604-1613.
36. Zhao, Y., Cao, X., Zheng, Y., Tang, J., Cai, W., Wang,H., Gao, Y. and Wang, Y. (2012) Relationship between cervical disease and infection with human papillomavirus types 16 and 18, and herpes simplex virus 1 and 2. J. Med. Virol., 84, 1920-1927.
37. Alberts, C.J., Schim van der Loeff, M.F., Papenfuss, M.R., da Silva, R.J., Villa, L.L., Lazcano-Ponce, E., Nyitray, A.G. and Giuliano, A.R. (2013) Association of chlamydia trachomatis infection and herpes simplex virus type 2 serostatus with genital human papillomavirus infection in men: the HPV in men study. Sex Transm. Dis., 40, 508-515.
38. DiPaolo, J.A., Woodworth, C.D., Coutlée, F., Zimonic, D.B., Bryant, J. and Kessous, A. (1998) Relationship of stable integration of herpes simplex virus-2 Bg/II N subfragment Xho2 to malignant transformation of human papillomavirus-immortalized cervical keratinocytes. Int. J. Cancer, 76, 865-871.
39. Partridge, J.M. and Koutsky, L.A. (2006) Genital human papillomavirus infection in men. Lancet Infect. Dis., 6, 21-31.
40. York, I.A., Roop, C., Andrews, D.W., Riddell, S.R., Graham, F.L. and Johnson, D.C. (1994) A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell, 77, 525-535.
41. Paludan, S.R., Malmgaard, L., Ellermann-Eriksen, S., Bosca, L. and Mogensen, S.C. (2001) Interferon (IFN)-gamma and herpes simplex virus/ tumor necrosis factor-alpha synergistically induce nitric oxide synthase 2 in macrophages through cooperative action of nuclear factor-kappa B and IFN regulatory factor-1. Eur. Cytokine Netw., 12, 297-308.
42. Cohen-Eliav, M., Golan-Gerstl, R., Siegfried, Z., Andersen, C.L., Thorsen, K. and Ørntoft, T.F. (2013) The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers. J. Pathol., 229, 630-639.
43. Oh, K.J., Kalinina, A., Wang, J., Nakayama, K., Nakayama, K.I. and Bagchi, S. (2004) The papillomavirus E7 oncoprotein is ubiquitinated by UbcH7 and Cullin 1- and Skp2-containing E3 ligase. J. Virol., 78, 5338-5346.
44. Donnelly, N., Gorman, A.M., Gupta, S. and Samali, A. (2013) The eIF2a kinases: their structures and functions. Cell Mol. Life Sci., 70, 3493-3511.
45. Ye, J., Kumanova, M., Hart, L.S., Sloane, K., Zhang, H., De Panis, D.N., Bobrovnikova-Marjon, E., Diehl, J.A., Ron, D. and Koumenis, C. (2010) The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation. EMBO J., 29, 2082-2096.
46. Ying, J., Li, H., Cui, Y., Wong, A.H., Langford, C. and Tao, Q. (2006) Epigenetic disruption of two proapoptotic genes MAPK10/JNK3 and PTPN13/FAP-1 in multiple lymphomas and carcinomas through hypermethylation of a common bidirectional promoter. Leukemia, 20, 1173-1175.
47. Zhang, Z., Huettner, P.C., Nguyen, L., Bidder, M., Funk, M.C., Li, J., Li, J. and Rader, J.S. (2006) Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer. Oncogene, 25, 5436-5445.
48. Bréhin, A.C., Casadémont, I., Frenkiel, M.P., Julier, C., Sakuntabhai, A. and Despre's, P. (2009) The large form of human 2',5' -oligoadenylate synthetase (OAS3) exerts antiviral effect against chikungunya virus. Virology, 384, 216-222.
49. Gangloff, Y.G., Pointud, J.C., Thuault, S., Carré, L., Romier, C., Muratoglu, S., Brand, M., Tora, L., Couderc, J.L. and Davidson, I. (2001) The TFIID components human TAF(II)140 and Drosophila BIP2 (TAF(II)155) are novel metazoan homologues of yeast TAF(II)47 containing a histone fold and a PHD finger. Mol. Cell Biol., 21, 5109-5121.
50. Price, A.L., Patterson, N.J., Plenge, R.M., Weinblatt, M.E., Shadick, N.A. and Reich, D. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet., 380, 904-909.
51. Speliotes, E.K., Willer, C.J., Berndt, S.I., Monda, K.L., Thorleifsson, G., Jackson, A.U., Lango Allen, H., Lindgren, C.M., Luan, J., Mägi, R. et al. (2010) Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat. Genet., 42, 937-948.
52. Delaneau, O., Zagury, J.F. and Marchini, J. (2013) Improved whole chromosome phasing for disease and population genetic studies. Nat. Methods., 10, 5-6.
53. Howie, B.N., Donnelly, P. and Marchini, J. (2009) A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet., 5, e1000529.
54. [1000] Genomes Project ConsortiumDurbin, R.M., Abecasis, G.R., Altshuler, D.L., Auton, A., Brooks, L.D., Durbin, R.M., Gibbs, R.A., Hurles, M.E. and McVean, G.A. (2010) A map of human genome variation from population-scale sequencing. Nature, 467, 1061-1073.
55. Benjamini, Y. and Hochberg,Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc.B, 57, 289-300.